Cytori Therapeutics Stock Climbs On Data Publication
Cytori Therapeutics Inc (NASDAQ: CYTX) Cytori Therapeutics is having a great day in the market today after announcing the publication of results from the one year clinical follow-up of patients enrolled in the Scleradec-1 clinical trail from hand dysfunction in patients with a rare disease known as scleroderma. Today, we’ll take a look at the … Read more